Literature DB >> 30187976

Bacteriology and clinical outcomes of patients with culture-positive pleural infection in Western Australia: A 6-year analysis.

Fraser Brims1,2, Natalia Popowicz1,3,4, Andrew Rosenstengel1, Julie Hart5, Arthee Yogendran1, Catherine A Read1, Felicity Lee1, Ranjan Shrestha1, Alexander Franke1, Joshua R Lewis6, Ian Kay7, Grant Waterer4,8, Y C Gary Lee1,4.   

Abstract

BACKGROUND AND
OBJECTIVE: Pleural infection is a clinical challenge; its microbiology can be complex. Epidemiological and outcome data of pleural infection in adult Australians are lacking. We describe the bacteriology and clinical outcomes of Australian adults with culture-positive pleural infection (CPPI) over a 6-year period.
METHODS: Cases with CPPI were identified through Western Australian public hospitals electronic record. Culture isolates, admission dates, vital status, co-morbidities, radiology, blood and pleural fluid tests were extracted.
RESULTS: In total, 601 cases (71.4% males; median age: 63 years (IQR: 50-74); median hospital stay 13 days) involving 894 bacterial isolates were identified. Hospital-acquired (HA)-CPPI was defined in 398 (66.2%) cases, community-acquired (CA)-CPPI in 164 (27.3%) cases and the remaining classified as oesophageal rupture/leak. Co-morbidities, most frequently cancer, were common (65.2%). Radiological evidence of pneumonia was present in only 43.8% of CA-CPPI and 27.3% of HA-CPPI. Of the 153 different bacterial strains cultured, Streptococcus species (32.9%) especially viridans streptococci group were most common in CA-CPPI, whereas HA-CPPI was most often associated with Staphylococcus aureus (11.6%) and Gram-negative (31.9%) infections. Mortality was high during hospitalization (CA-CPPI 13.4% vs HA-CPPI 16.6%; P = 0.417) and at 1 year (CA-CPPI 32.4% vs HA-CPPI 45.5%; P = 0.006).
CONCLUSION: This is the first large multicentre epidemiological study of pleural infection in Australian adults and includes the largest cohort of HA-CPPI published to date. CPPI is caused by a diverse range of organisms which vary between CA and HA sources. CPPI is a poor prognostic indicator both in the short term and in the subsequent 12 months.
© 2018 Asian Pacific Society of Respirology.

Entities:  

Keywords:  bacteria; empyema, pleural; survival

Year:  2018        PMID: 30187976     DOI: 10.1111/resp.13395

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  5 in total

1.  A systematic review of comorbidities and outcomes of adult patients with pleural infection.

Authors:  Tamsin N Cargill; Maged Hassan; John P Corcoran; Elinor Harriss; Rachelle Asciak; Rachel M Mercer; David J McCracken; Eihab O Bedawi; Najib M Rahman
Journal:  Eur Respir J       Date:  2019-10-01       Impact factor: 16.671

2.  Identification of Microbiome Etiology Associated With Drug Resistance in Pleural Empyema.

Authors:  Zhaoyan Chen; Hang Cheng; Zhao Cai; Qingjun Wei; Jinlong Li; Jinhua Liang; Wenshu Zhang; Zhijian Yu; Dongjing Liu; Lei Liu; Zhenqiang Zhang; Ke Wang; Liang Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-16       Impact factor: 5.293

3.  Asymptomatic man with an incidental finding of a massive empyema.

Authors:  Kashvi Gupta; Elena Stuewe; Marianne Barry
Journal:  BMJ Case Rep       Date:  2020-09-10

4.  Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial.

Authors:  José M Porcel; Lucia Ferreiro; Laura Rumi; Esther Espino-Paisán; Carmen Civit; Marina Pardina; Juan Antonio Schoenenberger-Arnaiz; Luis Valdés; Silvia Bielsa
Journal:  Pleura Peritoneum       Date:  2020-02-26

Review 5.  Recent Insights into the Management of Pleural Infection.

Authors:  Maged Hassan; Shefaly Patel; Ahmed S Sadaka; Eihab O Bedawi; John P Corcoran; José M Porcel
Journal:  Int J Gen Med       Date:  2021-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.